Taro Pharmaceutical Industries ROE 2006-2020 | TARO

Current and historical return on equity (ROE) values for Taro Pharmaceutical Industries (TARO) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Taro Pharmaceutical Industries ROE for the three months ending March 31, 2020 was 11.94%.
Taro Pharmaceutical Industries ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2020-03-31 $0.24B $2.11B 11.92%
2019-12-31 $0.25B $2.07B 12.42%
2019-09-30 $0.27B $2.03B 14.12%
2019-06-30 $0.28B $1.98B 13.91%
2019-03-31 $0.28B $1.91B 13.45%
2018-12-31 $0.31B $1.85B 14.28%
2018-09-30 $0.23B $2.35B 10.35%
2018-06-30 $0.22B $2.28B 10.02%
2018-03-31 $0.21B $2.21B 9.58%
2017-12-31 $0.21B $2.20B 9.59%
2017-09-30 $0.33B $2.21B 15.61%
2017-06-30 $0.40B $2.15B 19.70%
2017-03-31 $0.46B $2.07B 23.10%
2016-12-31 $0.49B $2.00B 25.15%
2016-09-30 $0.54B $1.92B 27.90%
2016-06-30 $0.55B $1.92B 29.53%
2016-03-31 $0.54B $1.94B 30.83%
2015-12-31 $0.58B $1.94B 35.57%
2015-09-30 $0.53B $1.62B 36.09%
2015-06-30 $0.54B $1.53B 39.55%
2015-03-31 $0.48B $1.42B 38.42%
2014-12-31 $0.42B $1.32B 36.36%
2014-09-30 $0.40B $1.20B 37.09%
2014-06-30 $0.35B $1.09B 33.96%
2014-03-31 $0.36B $1.02B 36.57%
2013-12-31 $0.32B $0.95B 33.52%
2013-09-30 $0.29B $1.04B 31.53%
2013-06-30 $0.26B $0.94B 30.50%
2013-03-31 $0.27B $0.89B 33.41%
2012-12-31 $0.26B $0.85B 36.20%
2012-09-30 $0.24B $0.76B 35.91%
2012-06-30 $0.23B $0.69B 38.79%
2012-03-31 $0.20B $0.62B 37.83%
2011-12-31 $0.18B $0.57B 37.44%
2011-09-30 $0.13B $0.50B 28.36%
2011-06-30 $0.09B $0.46B 21.82%
2011-03-31 $0.07B $0.42B 20.09%
2010-12-31 $0.05B $0.38B 17.61%
2010-09-30 $0.06B $0.30B 22.69%
2010-06-30 $0.05B $0.26B 20.60%
2010-03-31 $0.04B $0.25B 18.57%
2009-09-30 $0.04B $0.23B 18.87%
2009-06-30 $0.04B $0.21B 20.85%
2008-09-30 $0.02B $0.21B 9.90%
2006-03-31 $0.01B $0.24B 1.62%
2005-12-31 $0.01B $0.24B 1.46%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $2.505B $0.645B
Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals used in their production. Products are sold through wholesalers, generic drug distributors, drug store chains, mass merchandisers, HMOs, food stores, pharmacies and hospitals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $66.682B 37.84
Takeda Pharmaceutical (TAK) Japan $54.637B 9.57
Astellas Pharma (ALPMY) Japan $29.826B 15.11
UCB SA (UCBJF) Belgium $24.547B 0.00
Eisai (ESALY) Japan $23.752B 20.59
Merck (MKGAF) Germany $16.026B 21.02
Grifols, S.A (GRFS) Spain $13.215B 16.43
Catalent (CTLT) United States $12.286B 47.50
Neurocrine Biosciences (NBIX) United States $12.176B 56.28
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.568B 45.56
IPSEN SA ADR (IPSEY) France $7.709B 0.00
Orion OYJ (ORINY) Finland $7.077B 31.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.349B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.939B 9.50
United Therapeutics (UTHR) United States $5.210B 9.87
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.818B 526.00
Nektar Therapeutics (NKTR) United States $4.199B 0.00
Evotec AG (EVTCY) Germany $4.040B 108.88
FibroGen (FGEN) United States $3.748B 0.00
Hypermarcas (HYPMY) Brazil $3.724B 13.70
ChemoCentryx (CCXI) United States $3.625B 0.00
PTC Therapeutics (PTCT) United States $3.566B 0.00
Pacira BioSciences (PCRX) United States $2.331B 47.70
Sage Therapeutics (SAGE) United States $2.266B 0.00
Cronos Group (CRON) Canada $2.233B 64.00
Corcept Therapeutics (CORT) United States $1.869B 18.53
Xencor (XNCR) United States $1.825B 0.00
USANA Health Sciences (USNA) United States $1.786B 18.32
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.631B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.629B 12.46
Akebia Therapeutics (AKBA) United States $1.551B 0.00
Zogenix (ZGNX) United States $1.516B 0.00
Heron Therapeutics (HRTX) United States $1.487B 0.00
Indivior (INVVY) United States $1.421B 17.64
Karyopharm Therapeutics (KPTI) United States $1.412B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.398B 15.06
Theravance Biopharma (TBPH) Cayman Islands $1.339B 0.00
Esperion Therapeutics (ESPR) United States $1.310B 0.00
VAXART, INC (VXRT) United States $1.259B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.200B 0.00
Translate Bio (TBIO) United States $1.164B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.034B 46.13
Tilray (TLRY) Canada $0.945B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.923B 0.00
Endo (ENDP) Ireland $0.774B 1.20
ImmunoGen (IMGN) United States $0.749B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.695B 0.00
Trillium Therapeutics (TRIL) Canada $0.622B 0.00
Radius Health (RDUS) United States $0.614B 0.00
Aerie Pharmaceuticals (AERI) United States $0.611B 0.00
Collegium Pharmaceutical (COLL) United States $0.572B 0.00
Ardelyx (ARDX) United States $0.568B 0.00
Molecular Templates (MTEM) United States $0.558B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.524B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.513B 12.40
Flexion Therapeutics (FLXN) United States $0.506B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.500B 0.00
Innate Pharma SA (IPHYF) France $0.497B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.481B 18.78
Siga Technologies (SIGA) United States $0.477B 0.00
Altimmune (ALT) United States $0.451B 0.00
DURECT (DRRX) United States $0.419B 0.00
TherapeuticsMD (TXMD) United States $0.405B 0.00
Ocular Therapeutix (OCUL) United States $0.403B 0.00
Harpoon Therapeutics (HARP) United States $0.376B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.373B 0.00
MEI Pharma (MEIP) United States $0.359B 0.00
Calithera Biosciences (CALA) United States $0.359B 0.00
Organogenesis Holdings (ORGO) United States $0.349B 0.00
Concert Pharmaceuticals (CNCE) United States $0.303B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.287B 0.00
IMV INC (IMV) Canada $0.286B 0.00
PROFOUND MEDICL (PROF) Canada $0.267B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.253B 0.00
Taiwan Liposome (TLC) Taiwan $0.231B 0.00
Redhill Biopharma (RDHL) Israel $0.225B 0.00
OptiNose (OPTN) United States $0.218B 0.00
CASI Pharmaceuticals (CASI) United States $0.212B 0.00
Rafael Holdings (RFL) United States $0.208B 0.00
KalVista Pharmaceuticals (KALV) United States $0.206B 0.00
Lannett Co Inc (LCI) United States $0.198B 4.34
Nature's Sunshine Products (NATR) United States $0.188B 24.77
Jounce Therapeutics (JNCE) United States $0.174B 4.16
Nivalis Therapeutics (ALPN) United States $0.168B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.149B 0.00
Aquestive Therapeutics (AQST) United States $0.139B 0.00
Otonomy (OTIC) United States $0.124B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.117B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.114B 0.00
Xeris Pharmaceuticals (XERS) United States $0.106B 0.00
Champions Oncology (CSBR) United States $0.105B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.103B 0.00
MediWound (MDWD) Israel $0.103B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.102B 0.00
Heat Biologics (HTBX) United States $0.100B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.100B 0.00
Recro Pharma (REPH) United States $0.098B 0.00
Onconova Therapeutics (ONTX) United States $0.094B 0.00
CTI BioPharma (CTIC) United States $0.092B 0.00
Sundial Growers (SNDL) Canada $0.090B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.090B 0.00
Biomerica (BMRA) United States $0.086B 0.00
Hemispherx BioPharma (AIM) United States $0.085B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.082B 0.00
ElectroCore (ECOR) United States $0.070B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.068B 0.00
SCYNEXIS (SCYX) United States $0.067B 0.00
RENEURON GP (RNUGF) United Kingdom $0.059B 0.00
Lipocine (LPCN) United States $0.059B 0.00
Addex Therapeutics (ADXN) Switzerland $0.057B 0.00
CV Sciences (CVSI) United States $0.056B 0.00
PolarityTE (PTE) United States $0.053B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 28.91
Natural Alternatives (NAII) United States $0.047B 0.00
Infinity Pharmaceuticals (INFI) United States $0.047B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.045B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.045B 0.00
IsoRay (ISR) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.041B 0.00
Mannatechorporated (MTEX) United States $0.041B 7.70
Novan (NOVN) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 85.18
NovaBay Pharmaceuticals (NBY) United States $0.038B 0.00
Jaguar Animal Health (JAGX) United States $0.037B 0.00
GTx (ONCT) United States $0.036B 0.00
AgeX Therapeutics (AGE) United States $0.034B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.033B 0.00
Neos Therapeutics (NEOS) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.024B 0.00
India Globalization Capital (IGC) United States $0.021B 0.00
ProPhase Labs (PRPH) United States $0.019B 0.00
Bio-Path Holdings (BPTH) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.018B 0.00
Iterum Therapeutics (ITRM) Ireland $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.017B 0.00
Regulus Therapeutics (RGLS) United States $0.016B 0.00
Can-Fite Biopharma (CANF) Israel $0.016B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.013B 0.00
Cyanotech (CYAN) United States $0.013B 31.57
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Shineco (TYHT) China $0.013B 0.00
China SXT Pharmaceuticals (SXTC) China $0.012B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.008B 0.00
Vical (BBI) United States $0.008B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00